23.89
Updated 23/09/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 565,266
High 24.39
Low 23.87
Open 24.30
ISIN ES0171996087
Prev close 23.89
# of shares -
Market cap -
Intraday

Market closed
Grifols S.A.
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  23.89 -2.8% Stock price decreasing -5.6% Stock price decreasing -8.7% Stock price decreasing 9.8% Stock price increasing -0.1% Stock price decreasing
Powered by TradingView

Company profile

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 September 2018 02:47:41
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB7 - 2018-09-26 03:47:41 - 2018-09-26 02:47:41 - 1000 - Website: OKAY